On May 31, 2026, Ampharco U.S.A, an EU-GMP certified pharmaceutical manufacturer, proudly sponsored the 22nd Annual Scientific Conference of the Ho Chi Minh City Dermatology Association, with the theme "Dermatology in the Era of Regenerative Medicine".
The conference provided a valuable opportunity for the company to connect with dermatology experts, learn about the latest treatment trends, and continue supporting the development of dermatology in Vietnam.
Supporting the Development of Dermatology
Improving product quality has always been one of Ampharco U.S.A's main priorities. In 2025, the company's factory received EU-GMP certification, demonstrating its commitment to producing pharmaceutical products that meet high international quality standards.
Along with its other key product groups, dermatology is one of the company's major focus areas.
Today, Ampharco U.S.A offers a range of well-known dermatology products, including Soslac G3, Maxxacne-C, Maxxacne-AC, and Soscort. These products help support the treatment and care of common skin conditions. Their use in daily medical practice encourages the company to continue improving product quality while meeting the changing needs of healthcare professionals and patients.
Updating the Latest Trends in Dermatology Care
As part of this commitment, Ampharco U.S.A proudly sponsored the 22nd Annual Scientific Conference of the Ho Chi Minh City Dermatology Association, one of Vietnam's leading scientific events in dermatology.
The conference brought together around 500 doctors, pharmacists, and healthcare professionals from across the country. It featured many scientific presentations on regenerative medicine, modern treatment methods, and the latest advances in dermatology.
The event allowed participants to exchange practical experience, update their professional knowledge, and discuss new approaches to patient care.
For Ampharco U.S.A, the conference was also a good opportunity to introduce its dermatology products and treatment solutions to the medical community. At the same time, the company was able to strengthen its relationships with healthcare professionals and gain a better understanding of clinical needs, helping it continue to improve its products and better serve patients.
By sponsoring the conference, Ampharco U.S.A once again showed its commitment to quality, science, and continuous improvement. The company will continue working closely with the medical community, supporting scientific activities and developing high-quality products that contribute to better healthcare for Vietnamese patients.